When released in response to food intake, GLP-1 helps to: Increase insulin secretion Decrease glucagon secretion Slow gastric emptying Promote satiety By activating GLP-1 receptors in the brain and gastrointestinal tract, these medications help individuals feel fuller for longer periods, ultimately leading to reduced caloric intake and weight loss
Purpose of a GLP-1 Weight Loss Trial The primary goal of a GLP-1 weight loss clinical trial is to evaluate how effective and safe these medications are in helping individuals lose weight
This might include specific directions on when to take each medication, how often to take it, and what to avoid while on the medication
, Gavrilova, O
As in the shorter-term studies, DPP-4 inhibition was well-tolerated with no increased risk of hypoglycaemia, despite the improvement in glycaemic control, and the overall adverse event profile was similar in both arms of the study
Setting reminders or using a weekly calendar can help keep you on track